Clinical Trial Update: CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Cross-Sectional Study

View source ↗

Summary

This report summarizes a completed cross-sectional study evaluating continuous subcutaneous insulin infusion (CSII) in Type 1 diabetes, focusing on diet and qua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Liverpool John Moores University | Conditions: Type 1 Diabetes | Status: COMPLETED